Risk Factors for Cognitive Change in Parkinson's Disease from the Framingham Study05/02/2014 - 04/30/2016 (Co-Investigator)
PI:
Rhoda Au, PhDNational Parkinson Foundation Inc
Mortality in PD: The PEACE Consortium09/01/2014 - 08/31/2015 (PI)
American Parkinson Disease Association, Inc.
Supplemental Analyses of Tetra HD and the Open Label Study to Address Unanswered Questions Regarding the Impact of Concomitant Depression and Antidepressant Use, Value, of Tetrabenazine02/01/2011 - 01/31/2012 (Subcontract PI)
University of Rochester Lundbeck, Inc
Cooperative Huntington's Observational Research Trial (COHORT)07/01/2005 - 06/30/2011 (PI)
HP Therapeutics Foundation, Inc.
PARS- Parkinson's Associated Risk Study04/04/2007 - 04/03/2011 (PI)
The Institute for Neurodegenerative Disorders
Fox Investigation for New Discovery of Biomarkers (BioFIND)11/26/2013 - 12/31/2015 (PI)
Michael J. Fox Foundation
Protocol Number: SD-809-C-09. A Randomized, double-blinded, placebo-controlled trial to evaluate the04/16/2013 - 12/31/2015 (PI)
Huntington Study Group, Ltd. Auspex Pharmaceutica
An Interdisciplinary Approach to Accommodate Fine Motor Control Disorders10/01/2011 - 09/30/2014 (PI)
Northeastern University National Science Fdn
Coenzyme Q10 in Huntington's Disease12/01/2007 - 07/31/2014 (PI)
Mass General Hosp NIH-NINDS5U01 NS052592-05
Ethics of Sham Surgery Controls to test Novel PD interventions03/01/2009 - 02/28/2011 (PI)
UNIV OF MICHIGAN NIH-NINDS
PROBE11/08/2006 - 11/07/2009 (PI)
University of Rochester Dept of Defense